Zika and the Blood Supply: A Work in Progress

Area of Science:

• Transfusion Medicine
• Infectious Diseases
• Public Health

Background:

• Zika virus transmission via blood transfusion is confirmed, but recipient harm is often unclear.
• Potential for Zika virus transmission through organ transplantation poses an additional public health concern.
• Fetal neurological damage associated with Zika virus elevates concerns regarding transfusion safety.

Purpose of the Study:

• To review current strategies for mitigating Zika virus transmission risks in blood transfusion and organ transplantation.
• To assess the efficacy of various interventions in different epidemiological settings.
• To inform decision-making frameworks for blood product safety during Zika virus outbreaks.

Main Methods:

• Review of existing literature and public health guidelines on Zika virus transmission and prevention.
• Analysis of risk mitigation strategies, including donor deferral, nucleic acid testing, and pathogen reduction.
• Examination of regional variations in intervention implementation (e.g., US, Canada).

Main Results:

• Transfusion and organ transplant transmission routes are plausible, with significant risk to fetuses.
• Intervention effectiveness varies by geographic region (endemic vs. non-endemic).
• Current US strategies combine travel deferrals and testing, with mandated investigational universal testing for blood donors in high-risk areas.

Conclusions:

• A multi-faceted approach combining donor screening, advanced testing, and pathogen reduction is essential for protecting recipients.
• Risk assessment and adaptive strategies are necessary due to the evolving nature of Zika virus epidemics.
• Continued vigilance and research are required to optimize blood product safety globally.